alt_routeBuying guide

Where to Buy Epithalon

Five channels sorted by what they actually produce and when: one delivers inside a week, two take a month, one never completes, and one has no clock at all.

Where to buy epithalon has five real answers, and sorting them by price hides the thing that separates them. Sorted by elapsed time and outcome, the map is much shorter than the search results suggest.

Epithalon is a synthetic tetrapeptide, four residues in the sequence Ala-Glu-Asp-Gly, spelled Epitalon by FDA and PubChem and Epithalon by almost everyone selling it. Everything described here is research material for laboratory use and not for human consumption, and the links to the supplier below are affiliate links.

Most readers end up in the first row of the table, so the listing it refers to is worth having in view.

Where the order actually gets placed

Ascension Peptides, Epithalon

US-based and third-party tested. Enter the code on the payment step and the vial halves before you confirm.

CodePEPTIDEDECK50% off

Epithalon · 10 mg$50.00$25.00Get the 10 mg →

The certificate for batch 15-05260628 assays this vial at 9.64 mg against a 10 mg label, inside the stated 10 percent tolerance, which puts the real figure at $2.59/mg on that batch. It carries purity, identity, endotoxin, sterility and heavy metals. Buying 3, 5 or 10 takes 3%, 5% or 10% off list.

Two batch certificates per lot
Shipping free over $250
Out the door same day if you order before 2pm CST

Everything here is research material for laboratory use, not for human consumption. Affiliate links, so we may earn a commission at no cost to you. Prices last checked August 23, 2026.

Where to buy epithalon: five channels, three outcomes

| Channel | What you get | Elapsed time | Cost for 10 mg | Main risk | |---|---|---|---|---| | US research supplier | Sealed lyophilised vial, one batch certificate covering the full panel | Same-day dispatch, days in transit | $25.00 with the code | Sold for laboratory use, with no human data behind it | | Longevity or anti-ageing clinic | A consultation, a programme, sometimes a vial | Weeks, most of it waiting on an appointment | Rarely published in advance | Marketing claims running ahead of the evidence | | Overseas marketplace | Powder by the gram, usually a product-level certificate | Two to six weeks, clearance dependent | Lower headline, plus duty and handling | Refusal at the border, and no recourse afterwards | | Compounding pharmacy | Nothing | Does not complete | Not applicable | Time lost, and a warning sign if one agrees | | Group buy or reseller | Decanted or relabelled material | Days to never | Cheapest headline | No chain back to any lot |

The rest of this page is what sits behind each row, grouped by when it ends.

Same week: the domestic research supplier

This is the only row where the clock is under anyone's control, and the reason is inventory. A seller holding stock in the United States can state a dispatch cutoff as a time of day, because picking and labelling is a task it performs. It cannot promise a delivery date, because once the label prints the parcel belongs to a carrier.

What makes this channel checkable is the document. The certificate for batch 15-05260628, report KVR-2026-A36FF4 from Kovera Labs, certified 05/23/2026, reports 99.312% purity against a specification of 98 percent or better by RP-HPLC, identity confirmed by LC-MS, an endotoxin safety screen passing against a limit of 0.5 EU/mL, a microbial sterility screen showing no growth, and negative heavy metals screening for arsenic, cadmium, lead and mercury.

It also reports net content of 9.64 mg in a vial labelled 10 mg, against a specification written as 10 mg plus or minus 10 percent. That is inside the tolerance and under the label, and it is the most useful line in the document, because it is a number the seller had no commercial reason to print. It moves the real cost on that batch from $2.50 per milligram to $2.59.

Commercially the row reads: $50.00 list, down from $69.99, $25.00 with the code PEPTIDEDECK, tiers of 3, 5 or 10 vials taking 3%, 5% or 10% off list with no published indication that they stack with the code, and free shipping from $250.

Next month: the clinic with a waiting room

Epithalon is unusual among research peptides in that a genuine clinic channel exists. Longevity, anti-ageing and wellness practices do market it, and anyone searching for where to buy epithalon peptide locally will find them.

What such a practice sells is a sequence rather than a product: an intake appointment, often a panel of bloodwork, a programme, and somewhere near the end of that a vial. The elapsed time is dominated by the first step. Two to four weeks to an appointment is ordinary, and nothing about the compound shortens it.

The honest caution here is about claims rather than about clinics. This compound is marketed on telomere and lifespan arguments that rest largely on Russian-language work from one research group in St Petersburg, and a consultation room is a persuasive setting for material that has never been approved by FDA for anything. Reporting that those claims are made is accurate. Adopting them is not, and a clinical setting does not convert a claim into a finding.

The practical question to ask is the same one you would ask a website. Which laboratory tested the batch you would be given, what did the report cover, and can you see it.

Next month, if it clears: the overseas marketplace

Bulk sellers quote grams, and a gram beside a 10 mg vial looks decisive until the rest of the transaction is priced.

International shipping is the small cost. The larger ones are that FDA's personal importation guidance treats unapproved drugs as generally subject to refusal, that UK and EU buyers pay VAT and a carrier handling fee on delivery, and that a parcel stopped at a border leaves you disputing a charge with a business no regulator you can reach has any interest in.

The certificate problem is separate and structural. These sellers typically publish one document per product rather than one per lot, which means the paper cannot be tied to the material that reached you. A purity figure belonging to some other batch is not evidence about your vial, no matter how good the figure is.

Never: the compounding pharmacy

This is the row that consumes the most time for the least return, because the reasoning behind it is rarely stated on the pages that send people there.

A 503A pharmacy compounding from a bulk drug substance needs that substance to have an applicable USP monograph, to be a component of an FDA-approved drug, or to appear on the bulks list at 21 CFR 216.23. Epitalon satisfies none of the three. On FDA's compounding safety page, current as of 04/22/2026, it appears in the table of bulk drug substances nominated but withdrawn. It was nominated, it sat in category 2 under the interim policies, and then the nomination was pulled before any determination was reached. It is not banned, and it is not in category 2 today. It is on no current list at all.

FDA's stated concern about the substance is that compounded drugs containing epitalon may pose a risk of immunogenicity for certain routes of administration because of potential aggregation and peptide-related impurities, and that the agency lacks the information to know whether it would cause harm in humans. That is a testing and evidence problem, not a scheduling one, and it is why the withdrawal matters less than people assume: nothing was decided.

The consequence for a buyer is blunt. There is no prescription to obtain, so there is nothing for a pharmacy to fill, and a pharmacy that offers to supply it anyway has told you something about itself. The Semax version of this same withdrawn nomination reads almost identically, which is a useful cross-check on whether a page you are reading understands the position or is guessing.

No clock at all: group buys and resellers

Forum splits, group buys and social sellers decant bulk material into unlabelled vials. Whatever the source material was, the chain back to a certificate breaks at the moment of decanting, and a screenshot of someone else's PDF does not repair it.

This channel also has no reorder path worth planning around. The seller who replied to messages in March is often gone by June, which matters because consistency between orders is the only informal quality signal available to a buyer who cannot test material.

What separates the rows besides the calendar

Recourse, which nobody thinks about until it is needed. A domestic seller is reachable by a card issuer, a carrier claim and a consumer regulator. An overseas marketplace is reachable by none of them. A clinic sits inside a professional complaints system, which is real but slow and concerns the practitioner rather than the powder. A reseller sits outside every one of those systems by design.

Documentation is the other. Only two rows can produce a document tied to a specific batch, and one of them has to be asked. The rest either publish a document that describes different material or publish nothing, and no amount of waiting changes that.

Common questions

Common Concerns

Why is a compounding pharmacy listed as never rather than as slow?expand_more

Because the obstacle is structural rather than a queue. A 503A pharmacy compounding from a bulk substance needs that substance to be the subject of an applicable USP monograph, a component of an FDA-approved drug, or listed on the bulks list in 21 CFR 216.23. Epitalon is none of the three. Its nomination for that list was withdrawn before any determination was reached, so it sits on no current category list at all. There is no prescription to write and therefore nothing to fill, and more patience produces nothing.

Do longevity clinics really sell this, or is that a myth?expand_more

They really do market it, which sets it apart from most research peptides, and that is worth stating plainly rather than pretending the channel does not exist. What a clinic sells is a consultation, a programme and sometimes a vial, and the marketing generally leans on telomere and lifespan claims that trace back largely to Russian-language work from one research group. The clinic is not evidence for those claims. It is a retailer with a waiting room, and the same batch certificate question applies to it as to a website.

How much of the overseas wait is shipping?expand_more

Usually the smaller part. A parcel can fly in three days and then sit at a border facility for longer than it spent in the air, and the outcome of that pause is binary rather than gradual. FDA's personal importation guidance treats unapproved drugs as generally subject to refusal, so the parcel is not guaranteed to complete the trip at all. When someone says an international peptide order took a month, transit was rarely more than a week of it.

Is the domestic channel legal?expand_more

It is a research-use sale, which is a different thing from an approved medicine and a different thing again from something prohibited. Epithalon has no FDA approval for any indication, and material sold on this basis is sold for laboratory use rather than for administration to a person. FDA has separately said it lacks the information to know whether epitalon would cause harm if given to humans, citing potential immunogenicity from aggregation and peptide-related impurities. None of the five channels changes either fact.

Why does the domestic supplier row list only one certificate?expand_more

Because that is what exists for this compound. The product publishes a single report, KVR-2026-A36FF4 from Kovera Labs, covering batch 15-05260628, and unusually for a single document it carries the whole panel: purity, identity, endotoxin, sterility and heavy metals. Some compounds from the same seller carry two reports from two laboratories. Here there is one, and its breadth rather than its count is what makes it useful.

Which channel do most people actually end up in?expand_more

The domestic research supplier, and usually by elimination rather than preference. The pharmacy route closes on the regulatory position, the overseas route trades weeks and recourse for a headline price, the grey market cannot connect any document to the vial it ships, and the clinic route adds an appointment and a programme in front of the same underlying material. What is left is a listing that publishes a batch number, which is the only channel where the other questions can even be asked.

Keep exploring

For the same map drawn around a compound with no clinic row at all, the Selank channels and what each one costs in waiting is the closest structural comparison on this site. Where the clinic channel is the dominant one rather than the unusual one, the NAD+ split between booking a chair and waiting on a box shows how the arithmetic changes, including what to ask a practice that mixes its own.